| 000 | 01818 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250515114447.0 | ||
| 264 | 0 | _c20080619 | |
| 008 | 200806s 0 0 eng d | ||
| 022 | _a1460-2091 | ||
| 024 | 7 |
_a10.1093/jac/dkn127 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMasquelier, B | |
| 245 | 0 | 0 |
_aClinically validated mutation scores for HIV-1 resistance to fosamprenavir/ritonavir. _h[electronic resource] |
| 260 |
_bThe Journal of antimicrobial chemotherapy _cJun 2008 |
||
| 300 |
_a1362-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmino Acid Substitution _xgenetics |
| 650 | 0 | 4 |
_aCarbamates _xpharmacology |
| 650 | 0 | 4 | _aDrug Resistance, Viral |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFurans |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV Protease Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aHIV-1 _xclassification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 |
_aOrganophosphates _xpharmacology |
| 650 | 0 | 4 |
_aRNA, Viral _xblood |
| 650 | 0 | 4 |
_aRitonavir _xpharmacology |
| 650 | 0 | 4 |
_aSulfonamides _xpharmacology |
| 650 | 0 | 4 | _aViral Load |
| 700 | 1 | _aAssoumou, K L | |
| 700 | 1 | _aDescamps, D | |
| 700 | 1 | _aBocket, L | |
| 700 | 1 | _aCottalorda, J | |
| 700 | 1 | _aRuffault, A | |
| 700 | 1 | _aMarcelin, A G | |
| 700 | 1 | _aMorand-Joubert, L | |
| 700 | 1 | _aTamalet, C | |
| 700 | 1 | _aCharpentier, C | |
| 700 | 1 | _aPeytavin, G | |
| 700 | 1 | _aAntoun, Z | |
| 700 | 1 | _aBrun-Vézinet, F | |
| 700 | 1 | _aCostagliola, D | |
| 773 | 0 |
_tThe Journal of antimicrobial chemotherapy _gvol. 61 _gno. 6 _gp. 1362-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/jac/dkn127 _zAvailable from publisher's website |
| 999 |
_c17890011 _d17890011 |
||